Vascepa is a prescription medication that is used to treat high levels of triglycerides in the blood. It contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. Vascepa is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia [1].

According to the official Vascepa website, the medication is covered by most insurance plans, including Medicare and Medicaid. However, coverage may vary depending on the specific plan and the patient's individual circumstances. The website also provides information about a savings program that may help eligible patients save on the cost of their Vascepa prescription [2].

The drug patent watch website provides information about the patent status of Vascepa and its generic versions. As of August 2021, Vascepa is still under patent protection, and no generic versions are available [3].

A recent study published in the Journal of the American Heart Association found that Vascepa can reduce the risk of cardiovascular events in patients with high triglyceride levels and other risk factors, such as diabetes and metabolic syndrome. The study concluded that Vascepa may be a valuable treatment option for these patients [4].

In summary, Vascepa is a prescription medication used to treat high levels of triglycerides in the blood. It is covered by most insurance plans, including Medicare and Medicaid, and a savings program is available to eligible patients. The medication is still under patent protection, and a recent study found that it may be beneficial for patients with high triglyceride levels and other risk factors for cardiovascular disease.

Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202057s031lbl.pdf
[2] https://www.vascepa.com/getting-started/vascepa-savings/
[3] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379293/